Medicus Pharma MDCXW Growth Metrics (2024-2026)

NASDAQ MDCXW
$0.33 -0.11 (-24.95%)
At close: Aug 11, 2026 · 4:00 PM EDT
Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y) (Quarter) 198.29%78.18%127.21%
Assets (QoQ) (Quarter) 0.19%110.94%-16.40%0.84%
Cash & Equivalents Growth (1y) (Quarter) 142.21%109.04%56.93%
Cash & Equivalents (QoQ) (Quarter) -4.37%142.81%-10.42%0.50%
Cash from Operations Growth (1y) (Quarter) -234.85%-96.95%-117.85%-107.08%
Cash from Operations (QoQ) (Quarter) -135.93%-11.72%-2.89%-23.48%-38.77%-23.57%2.20%
EBIT Growth (1y) (Quarter) -200.25%-69.28%100.00%-117.28%-90.80%
EBIT (QoQ) (Quarter) -108.15%34.32%-53.60%-42.97%-17.36%100.00%-51,937,233.33%
EBT Growth (1y) (Quarter) -218.07%-77.53%89.15%-118.37%-95.52%
EBT (QoQ) (Quarter) -108.15%33.33%-52.81%-49.99%-16.18%95.93%-2,976.49%
Enterprise Value Growth (1y) (Quarter) -142.21%-106.52%-56.53%
Enterprise Value (QoQ) (Quarter) 4.37%-142.81%11.51%-0.51%
EPS (Basic) Growth (1y) (Quarter) -109.87%-1.52%94.24%-137.11%-61.59%
EPS (Basic) (QoQ) (Quarter) -105.82%44.96%-53.51%-20.67%0.44%96.88%-6,220.37%
EPS (Diluted) Growth (1y) (Quarter) -109.87%-1.52%94.24%-137.11%-61.59%
EPS (Diluted) (QoQ) (Quarter) -105.82%44.96%-53.51%-20.67%0.44%96.88%-6,220.37%
Free Cash Flow Growth (1y) (Quarter) -234.85%-96.95%-117.85%-107.08%
Free Cash Flow (QoQ) (Quarter) -135.93%-11.72%-2.89%-23.48%-38.77%-23.57%2.20%
Interest Coverage Ratio Growth (1y) (Quarter) 100.00%34.08%100.00%
Interest Coverage Ratio (QoQ) (Quarter) -53.60%84.73%-31.39%100.00%-115,560,151.87%
Net Cash Flow Growth (1y) (Quarter) 84.55%-27.70%216.49%103.88%
Net Cash Flow (QoQ) (Quarter) 768.33%-139.44%63.19%84.07%3,226.63%-36.46%-98.77%
Net Income Growth (1y) (Quarter) -218.07%-77.53%89.15%-118.37%-95.52%
Net Income (QoQ) (Quarter) -108.15%33.33%-52.81%-49.99%-16.18%95.93%-2,976.49%
Net Income towards Common Stockholders Growth (1y) (Quarter) -218.07%-77.53%88.72%-326.05%-95.52%
Net Income towards Common Stockholders (QoQ) (Quarter) -108.15%35.88%-55.20%-53.55%-16.18%95.93%-5,763.14%
Operating Income Growth (1y) (Quarter) -200.25%-69.28%100.00%-117.28%-90.80%
Operating Income (QoQ) (Quarter) -108.15%34.32%-53.60%-42.97%-17.36%100.00%-51,937,233.33%
Profit After Tax Growth (1y) (Quarter) -198.85%-70.01%-601.32%8.36%-89.19%
Profit After Tax (QoQ) (Quarter) -112.78%37.27%-55.20%-44.28%-21.04%-158.76%79.72%
Return on Assets Growth (1y) (Quarter) 1.00
Return on Assets (QoQ) (Quarter) 1.001.00-1.00
Return on Capital Employed Growth (1y) (Quarter) 0.64M
Return on Capital Employed (QoQ) (Quarter) -0.61M0.18M-1.83M
Share-based Compensation Growth (1y) (Quarter) -60.76%368.48%
Share-based Compensation (QoQ) (Quarter) 1,528.35%-200.00%-49.61%
Total Debt Growth (1y) (Quarter) 357.08%
Total Debt (QoQ) (Quarter) 45.01%-22.65%